Brittany Lacy
Nurse Practitioner · Hot Springs, ARNPI 1508282955
Payments from drug & device makers
Across 196 payments — averaging $14.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$936
- Pfizer$271
- Lilly USA, LLC$248
- GSK$247
- Novo Nordisk$171
- Amgen$123
- plus $857 from 27 others
What the payments were for
- Food & beverage$2,82299%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 73 | $936 |
| Pfizer | 16 | $271 |
| Lilly USA, LLC | 17 | $248 |
| GSK | 17 | $247 |
| Novo Nordisk | 11 | $171 |
| Amgen(2 entities) | 8 | $123 |
| AstraZeneca | 7 | $122 |
| Exact Sciences | 6 | $92 |
| Sumitomo Pharma America, Inc. | 5 | $74 |
| Abbott | 4 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $51 |
| Merck | 3 | $45 |
| Astellas Pharma US Inc | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Dexcom, Inc. | 2 | $33 |
| Lundbeck LLC | 2 | $32 |
| Sunovion Pharmaceuticals Inc. | 2 | $25 |
| Antares Pharma, Inc. | 1 | $21 |
| Seqirus USA Inc | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Edwards Lifesciences | 1 | $18 |
| Halozyme Inc | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Shield Therapeutics Inc | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| Alk-abello, Inc | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Inogen, Inc. | 1 | $2 |
How this compares
$2,852 in reported general payments places this provider in the 85th percentile of 697 nurse practitioner providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 57 | $64,863 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $54,354 |
| LinzessLinaclotide | 33 | $30,512 |
| OzempicSemaglutide | 24 | $23,234 |
| EliquisApixaban | 22 | $19,718 |
| JardianceEmpagliflozin | 20 | $17,240 |
| Breo ElliptaFluticasone/Vilanterol | 21 | $12,695 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 26 | $9,363 |
| FarxigaDapagliflozin Propanediol | 12 | $7,630 |
| XareltoRivaroxaban | 15 | $7,111 |
| Spiriva RespimatTiotropium Bromide | 12 | $5,953 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 63 | $2,312 |
| Omeprazole | 155 | $2,229 |
| Pregabalin | 27 | $2,048 |
| Metoprolol Succinate | 138 | $2,015 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $247 | $67,05055 claims |
| Lilly USA, LLCMounjaro | $248 | $64,86357 claims |
| AbbVieLinzess | $936 | $30,51233 claims |
| Novo NordiskOzempic | $171 | $23,23424 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $15 | $23,19332 claims |
| PfizerEliquis | $271 | $19,71822 claims |
| AstraZenecaFarxiga | $122 | $7,63012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 697 nurse practitioner providers in Arkansas.
Other nurse practitioner in Hot Springs
- Tiffany McConathyHot Springs$54K
- Virginia LaliberteHot Springs$21K
- Samantha WidemanHot Springs$14K
- Cody WilliamsHot Springs$12K
- Nan MeansHot Springs$7K
- Ragan ArrisonHot Springs$7K
- Laci PattonHot Springs$7K
- Samantha BollanHot Springs$7K
- Kayla HarringtonHot Springs$6K
- Mindy FarmerHot Springs$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.